2024 annual financial data
Harmony Biosciences Holdings 2024 Operating cash flow
Direct answer
Operating cash flow was 219,821,000 USD.
Operating income was 190,826,000 USD and net income was 145,493,000 USD.
Operating cash flow was 219,821,000 USD.
Get free Harmony Biosciences Holdings email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 714,734,000 USD
- Operating income
- 190,826,000 USD
- Net income
- 145,493,000 USD
- Operating cash flow
- 219,821,000 USD